• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EBI, LLC. BIOMET SPINALPAK / ORTHOPAK; STIMULATOR, BONE GROWTH, NON-INVASIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EBI, LLC. BIOMET SPINALPAK / ORTHOPAK; STIMULATOR, BONE GROWTH, NON-INVASIVE Back to Search Results
Model Number 106130-17
Medical Device Problem Code Patient-Device Incompatibility (2682)
Health Effect - Clinical Codes Rash (2033); Skin Inflammation/ Irritation (4545)
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported by the sales representative that the patient indicated that she developed a rash and had skin irritation while using orthopak unit.Later, the customer service representative called and patient stated that she wore 72r electrodes with cover patches for 20-22 hours.The patient stated that her skin is sensitive to adhesives and took break from treatment for two week until the skin cleared.Once she started using it again, the rash/ skin irritation developed again.The patient contacted their physician and were advised to switch to bhs unit.No further consequences has been reported.The 72r electrodes and cover patches were not returned for further evaluations.
 
Additional Manufacturer Narrative
Without a product return, no product evaluation is able to be conducted.The device history records are unable to be reviewed.Current information is insufficient to permit a valid conclusion about the cause of this event.If additional information is obtained that adds value to the relevant content of this report and/or a conclusion can be drawn, a follow up report will be sent.
 
Event or Problem Description
It was reported by the sales representative that the patient indicated that she developed a rash and had skin irritation while using orthopak unit.Later, the customer service representative called and patient stated that she wore 72r electrodes with cover patches for 20-22 hours.The patient stated that her skin is sensitive to adhesives and took break from treatment for two weeks until the skin cleared.Once she started using it again, the rash/ skin irritation developed again.The patient contacted their physician and were advised to switch to bhs unit.No further consequences has been reported.The 72r electrodes and cover patches were not returned for further evaluations.
 
Additional Manufacturer Narrative
Corrections in b4: date of the report and d2: common name.Additional information in d4: lot number, expiration date, h4: manufacture date, g3, h6 and h10: additional narrative.Estimated date of the event b3: january 2025.This follow-up report is being submitted to relay additional and corrected information.The cover patches were not returned to (b)(6) medical for evaluation.The reported event was unable to be confirmed due to limited information received from the customer.The device history record was reviewed, and no discrepancies related to the reported event were found.Root cause was unable to be determined as the necessary information to adequately investigate the reported event was not provided.If any further information is found which would change or alter any conclusions or information, a supplemental report will be filed accordingly.(b)(6) medical will continue to monitor trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOMET SPINALPAK / ORTHOPAK
Common Device Name
STIMULATOR, BONE GROWTH, NON-INVASIVE
Manufacturer (Section D)
EBI, LLC.
1 gatehall dr
suite 303
parsippany NJ 07054
Manufacturer (Section G)
EBI, LLC
1 gatehall dr
suite 303
parsippany NJ 07054
Manufacturer Contact
stephanie smith
1 gatehall dr
suite 303
parsippany, NJ 07054
9732999300
MDR Report Key21294760
Report Number0002242816-2025-00024
Device Sequence Number9208097
Product Code LOF
UDI-Device Identifier00812301020195
UDI-Public00812301020195
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
P850022
Exemption Number5645646
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 04/24/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date07/27/2025
Device Model Number106130-17
Device Lot Number231502
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer Not provided
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date02/03/2025
Supplement Report FDA Received Date04/25/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured11/07/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H10 NARRATIVE.; SEE H10 NARRATIVE.
Outcome Attributed to Adverse Event Required Intervention;
Patient Age75 YR
Patient SexFemale
Patient EthnicityNon Hispanic
-
-